Acadian Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $288K | Sell |
549
-33,449
| -98% | -$18.8M | ﹤0.01% | 1571 |
|
|
2026
Q1 | $19.1M | Buy |
33,998
+12,538
| +58% | +$8.04M | 0.03% | 386 |
|
|
2025
Q4 | $14.5M | Buy |
21,460
+20,094
| +1,471% | +$13.7M | 0.02% | 397 |
|
|
2025
Q3 | $869K | Buy |
1,366
+620
| +83% | +$376K | ﹤0.01% | 1086 |
|
|
2025
Q2 | $399K | Sell |
746
-1,775
| -70% | -$849K | ﹤0.01% | 1184 |
|
|
2025
Q1 | $1.06M | Sell |
2,521
-902
| -26% | -$392K | ﹤0.01% | 923 |
|
|
2024
Q4 | $1.41M | Sell |
3,423
-3,066
| -47% | -$1.34M | ﹤0.01% | 854 |
|
|
2024
Q3 | $3.28M | Sell |
6,489
-3,038
| -32% | -$1.48M | 0.01% | 605 |
|
|
2024
Q2 | $4.64M | Buy |
9,527
+5,308
| +126% | +$2.66M | 0.01% | 520 |
|
|
2024
Q1 | $2.28M | Buy |
4,219
+1,913
| +83% | +$1.05M | 0.01% | 627 |
|
|
2023
Q4 | $1.28M | Sell |
2,306
-2,770
| -55% | -$1.3M | 0.01% | 790 |
|
|
2023
Q3 | $2.22M | Sell |
5,076
-1,090
| -18% | -$544K | 0.01% | 667 |
|
|
2023
Q2 | $3.09M | Sell |
6,166
-672
| -10% | -$322K | 0.01% | 577 |
|
|
2023
Q1 | $3.42M | Buy |
6,838
+3,916
| +134% | +$1.87M | 0.02% | 561 |
|
|
2022
Q4 | $1.19M | Sell |
2,922
-384
| -12% | -$149K | 0.01% | 804 |
|
|
2022
Q3 | $1.08M | Sell |
3,306
-22,578
| -87% | -$8.29M | 0.01% | 787 |
|
|
2022
Q2 | $9.08M | Sell |
25,884
-171,367
| -87% | -$69.9M | 0.05% | 284 |
|
|
2022
Q1 | $108M | Sell |
197,251
-96,883
| -33% | -$51M | 0.44% | 62 |
|
|
2021
Q4 | $194M | Sell |
294,134
-89,944
| -23% | -$56.5M | 0.72% | 33 |
|
|
2021
Q3 | $239M | Buy |
384,078
+77,446
| +25% | +$52M | 0.91% | 18 |
|
|
2021
Q2 | $194M | Buy |
306,632
+223,042
| +267% | +$123M | 0.73% | 26 |
|
|
2021
Q1 | $40.9M | Buy |
83,590
+74,021
| +774% | +$37.1M | 0.16% | 134 |
|
|
2020
Q4 | $4.78M | Buy |
9,569
+6,127
| +178% | +$2.74M | 0.02% | 508 |
|
|
2020
Q3 | $1.35M | Buy |
3,442
+893
| +35% | +$330K | 0.01% | 790 |
|
|
2020
Q2 | $841K | Sell |
2,549
-320
| -11% | -$92.7K | ﹤0.01% | 1025 |
|
|
2020
Q1 | $695K | Buy |
2,869
+1,222
| +74% | +$319K | ﹤0.01% | 894 |
|
|
2019
Q4 | $431K | Buy |
+1,647
| New | +$434K | ﹤0.01% | 1112 |
|
|
2019
Q3 | – | Sell |
-356
| Closed | -$98K | – | 1931 |
|
|
2019
Q2 | $98K | Sell |
356
-5,665
| -94% | -$1.4M | ﹤0.01% | 1372 |
|
|
2019
Q1 | $1.35M | Sell |
6,021
-2,461
| -29% | -$508K | 0.01% | 801 |
|
|
2018
Q4 | $1.58M | Sell |
8,482
-53,685
| -86% | -$11M | 0.01% | 618 |
|
|
2018
Q3 | $15.5M | Buy |
62,167
+13,259
| +27% | +$3.22M | 0.06% | 234 |
|
|
2018
Q2 | $10.7M | Buy |
48,908
+46,703
| +2,118% | +$9.62M | 0.05% | 290 |
|
|
2018
Q1 | $422K | Sell |
2,205
-7,628
| -78% | -$1.41M | ﹤0.01% | 903 |
|
|
2017
Q4 | $1.54M | Sell |
9,833
-63,746
| -87% | -$10M | 0.01% | 609 |
|
|
2017
Q3 | $11.4M | Buy |
73,579
+15,515
| +27% | +$2.45M | 0.05% | 267 |
|
|
2017
Q2 | $9.37M | Buy |
58,064
+43,463
| +298% | +$7.06M | 0.04% | 286 |
|
|
2017
Q1 | $2.26M | Sell |
14,601
-8,311
| -36% | -$1.15M | 0.01% | 586 |
|
|
2016
Q4 | $2.69M | Buy |
22,912
+2,788
| +14% | +$318K | 0.01% | 528 |
|
|
2016
Q3 | $2.27M | Buy |
20,124
+19,988
| +14,697% | +$2.11M | 0.01% | 515 |
|
|
2016
Q2 | $13K | Buy |
136
+66
| +94% | +$5.67K | ﹤0.01% | 1180 |
|
|
2016
Q1 | $5K | Buy |
+70
| New | +$5.04K | ﹤0.01% | 1265 |
|
|
2015
Q1 | – | Sell |
-166
| Closed | -$12K | – | 1401 |
|
|
2014
Q4 | $12K | Sell |
166
-3,218
| -95% | -$226K | ﹤0.01% | 1105 |
|
|
2014
Q3 | $200K | Buy |
+3,384
| New | +$214K | ﹤0.01% | 771 |
|
|
2014
Q1 | – | Sell |
-5,828
| Closed | -$310K | – | 1006 |
|
|
2013
Q4 | $310K | Buy |
+5,828
| New | +$307K | ﹤0.01% | 753 |
|
Other funds holding IDXX
Acadian Asset Management's IDXX Position: Q2 2026 in Review
Acadian Asset Management reduced its Idexx Laboratories (IDXX) stake by 98% in Q2 2026, selling an estimated $18.8M and leaving 549 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #1571.
Acadian Asset Management first reported a position in IDXX in Q4 2013 and has held it in 44 quarters since. The position peaked at $239M in Q3 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Acadian Asset Management held 549 shares of Idexx Laboratories worth $288K as of Q2 2026.
- Acadian Asset Management sold 33,449 Idexx Laboratories shares in Q2 2026, an estimated $18.8M.
- Idexx Laboratories made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1571 holding.
- Acadian Asset Management first reported a position in Idexx Laboratories in Q4 2013 and has held it in 44 quarters since.
- Acadian Asset Management's Idexx Laboratories position peaked at $239M in Q3 2021.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.